Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 434 (7035), 917-21

Targeting the DNA Repair Defect in BRCA Mutant Cells as a Therapeutic Strategy

Affiliations

Targeting the DNA Repair Defect in BRCA Mutant Cells as a Therapeutic Strategy

Hannah Farmer et al. Nature.

Abstract

BRCA1 and BRCA2 are important for DNA double-strand break repair by homologous recombination, and mutations in these genes predispose to breast and other cancers. Poly(ADP-ribose) polymerase (PARP) is an enzyme involved in base excision repair, a key pathway in the repair of DNA single-strand breaks. We show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymatic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis. This seems to be because the inhibition of PARP leads to the persistence of DNA lesions normally repaired by homologous recombination. These results illustrate how different pathways cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may allow the design of specific and less toxic therapies for cancer.

Similar articles

See all similar articles

Cited by 1,779 articles

See all "Cited by" articles

Publication types

MeSH terms

Substances

Feedback